Skip to content

Option Care Health, Inc. OPCH Treasury Stock Acquired Average Cost Per Share

Treasury Stock Acquired Average Cost Per Share at other companies

Belden logo
BeldenBDC
$117.05+12.2%
CHE
ChemedCHE
$395.36-33.6%
CSX logo
CSXCSX
$39.02+23.2%
Community Financial System logo
Community Financial SystemCBU
$61.87
VeriSign logo
VeriSignVRSN
$234.88+4.0%
Sysco logo
SyscoSYY
$200M-50.0%

Other financials

Income statement

See full
Revenue$1.4B+1.3%
Gross profit$262.0M-0.4%
Operating income$72.5M-8.4%
Net income$45.3M-3.0%
EPS (diluted)$0.29+3.6%

Balance sheet

See full
Cash & equivalents$177.3M+3.5%
Total debt$1.3B+3.9%
Total equity$1.4B0.0%
Total assets$3.4B+2.2%

Cash flow

See full
Operating cash flow-$12.1M-67.9%
CapEx$9.0M-3.5%
Free cash flow-$21.2M-27.6%

Valuation

See full
Market cap$3.45B-27.1%

Profitability

See full
Gross margin19.2%-0.8pp
Operating margin5.8%-0.6pp
Net margin3.6%-0.5pp
FCF margin3.8%-2.9pp

Returns & leverage

See full
Return on equity15.3%-0.1pp
Debt / equity0.9×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by Option Care Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockAcquiredAverageCostPerShare.

The official record: Option Care Health, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Option Care Health, Inc.'s treasury stock acquired average cost per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Option Care Health, Inc.'s treasury stock acquired average cost per share?
Option Care Health, Inc. (OPCH) reported treasury stock acquired average cost per share of $33.16 in Q1 2026.
How has Option Care Health, Inc.'s treasury stock acquired average cost per share changed year-over-year?
Option Care Health, Inc.'s treasury stock acquired average cost per share increased by 1.0% year-over-year, from $32.83 to $33.16.
What does treasury stock acquired average cost per share mean?
The weighted average price paid by the company to repurchase its own common shares from the open market during the period. This metric is used to evaluate the company's capital allocation efficiency and the valuation at which management chooses to return capital to shareholders.